Literature DB >> 15943546

Syllogistic reasoning performance in MDMA (Ecstasy) users.

Catharine Montgomery1, John E Fisk, Russell Newcombe, Michelle Wareing, Philip N Murphy.   

Abstract

Previous research has demonstrated working memory and executive deficits in recreational users of MDMA (3,4-methylenedioxymethamphetamine; Ecstasy). In turn, both of these constructs have been implicated in syllogistic reasoning performance. Twenty-two MDMA users (mean age = 21.36) and 26 MDMA nonuser controls (mean age = 21.31) were tested on syllogisms of varying difficulty and on measures of working memory and executive functioning. MDMA users were significantly impaired in aspects of syllogistic reasoning, and the effect remained significant after the authors controlled for the use of other drugs. However, the MDMA-related variance was reduced to below statistical significance following control for group differences in working memory span. The results are consistent with the possibility that MDMA-related deficits in aspects of executive functioning result in impaired reasoning performance among MDMA users. Copyright 2005 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943546     DOI: 10.1037/1064-1297.13.2.137

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  9 in total

1.  Reasoning deficits in ecstasy (MDMA) polydrug users.

Authors:  John E Fisk; Catharine Montgomery; Michelle Wareing; Philip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

2.  The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.

Authors:  Catharine Montgomery; John E Fisk; Russell Newcombe; Phillip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 3.  Differential effects of ecstasy on short-term and working memory: a meta-analysis.

Authors:  Claire E Nulsen; Allison M Fox; Geoffrey R Hammond
Journal:  Neuropsychol Rev       Date:  2010-02-16       Impact factor: 7.444

4.  ERP evidence suggests executive dysfunction in ecstasy polydrug users.

Authors:  C A Roberts; S H Fairclough; J E Fisk; F Tames; C Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2013-03-27       Impact factor: 4.530

5.  Reasoning deficits among illicit drug users are associated with aspects of cannabis use.

Authors:  John E Fisk; Andy M Morley; Florentia Hadjiefthyvoulou; Catharine Montgomery
Journal:  Cogn Process       Date:  2014-04-11

6.  The nature of ecstasy-group related deficits in associative learning.

Authors:  Catharine Montgomery; John E Fisk; Russell Newcombe
Journal:  Psychopharmacology (Berl)       Date:  2005-01-25       Impact factor: 4.530

7.  Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.

Authors:  Krista Lisdahl Medina; Paula K Shear
Journal:  Drug Alcohol Depend       Date:  2006-10-30       Impact factor: 4.492

8.  Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.

Authors:  Cynthia A Crawford; Michael T Williams; Jodie L Kohutek; Fiona Y Choi; Shelly T Yoshida; Sanders A McDougall; Charles V Vorhees
Journal:  Brain Res       Date:  2006-02-14       Impact factor: 3.252

9.  Meta-analysis of executive functioning in ecstasy/polydrug users.

Authors:  C A Roberts; A Jones; C Montgomery
Journal:  Psychol Med       Date:  2016-03-11       Impact factor: 7.723

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.